Profile
Mark Engel is the founder of Excel PharmaStudies, Inc. He is currently the Chief Executive Officer & Director at Phagelux, Inc., the Chairman & Chief Executive Officer at Precisio Biotix Therapeutics, Inc., and the Chairman at Phagelux (Canada), Inc.
Mark Engel active positions
Companies | Position | Start |
---|---|---|
Excel PharmaStudies, Inc.
Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China. | Founder | - |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Chief Executive Officer | - |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Chairman | 11/03/2015 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Excel PharmaStudies, Inc.
Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China. | Commercial Services |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Health Technology |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Mark Engel